Huntington's Disease and Psychiatric Comorbidities: A Retrospective Study in Portugal

José Rocha1, Carolina Soares2, Manuel Gonçalves-Pinho3

  • 1Faculdade de Medicina. Universidade do Porto. Porto. Portugal.

Acta Medica Portuguesa
|November 8, 2025
PubMed

Insights

Psychiatric comorbidity in Huntington's disease patients in Portugal was linked to younger admission age and longer hospital stays. Early psychiatric screening and intervention are crucial for managing this neurodegenerative disorder.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Public Health

Background:

  • Huntington's disease is a progressive neurodegenerative disorder with motor, cognitive, and behavioral symptoms.
  • Psychiatric comorbidities are common in Huntington's disease and can impact outcomes.
  • Data on the prevalence and impact of psychiatric comorbidities in Portuguese Huntington's disease patients is limited.

Purpose of the Study:

  • To analyze the frequency of psychiatric comorbidities in hospitalized Huntington's disease patients in Portugal.
  • To determine the impact of psychiatric comorbidities on hospitalization characteristics.

Main Methods:

  • Retrospective observational study using administrative data from Portuguese public hospitals (2000-2016).
  • Analysis of 1667 hospitalizations for Huntington's disease (ICD-9-CM code 333.4).
  • Identification of psychiatric comorbidities (Clinical Classification Software codes 650-670) and analysis of age, length of stay, admission type, mortality, and costs.

Main Results:

  • 28.97% of Huntington's disease hospitalizations had a psychiatric comorbidity.
  • Patients with psychiatric comorbidity were younger at admission (aOR=1.32) and had longer hospital stays (aOR=1.88).
  • No association found between psychiatric comorbidity and mortality, admission type, or costs. An upward trend in admissions and comorbidity was observed.

Conclusions:

  • Psychiatric comorbidity in Huntington's disease is associated with younger age at admission and longer hospitalizations.
  • Highlights the importance of integrated psychiatric care for Huntington's disease patients.
  • Suggests early screening and intervention can improve outcomes and healthcare resource allocation.
Abstract

Related Concept Videos

Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
423
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
472
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
606